Related Experiment Video
Updated: Jul 30, 2025

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage
Kateryna Strubchevska1, Marko Kozyk1, Matthew R Jacobs1
1Internal Medicine, Beaumont Hospital, Royal Oak, USA.
Abstract:
Hydralazine is a potent vasodilating medication used as adjunctive therapy for the treatment of hypertension. Rarely, hydralazine may cause the development of antineutrophil cytoplasmic antibody vasculitis with the pulmonary-renal syndrome. We are presenting a case of hydralazine-associated vasculitis and pulmonary hemorrhage.
More Related Videos
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
07:29The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
Related Concept Videos
Antihypertensive Drugs: Vasodilators
Rheumatic Heart Disease I: Introduction
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Heart Failure III: Clinical Manifestations
Rheumatic Heart Disease IV: Nursing Management